Adverse Event Reporting with Immune Checkpoint Inhibitors in Older Patients: Age Subgroup Disproportionality Analysis in VigiBase

SIMPLE SUMMARY: Due to the changes that occur with aging in the immune system, older patients represent a subpopulation of concern for immune checkpoint inhibitor toxicity. This pharmacovigilance study aimed to assess whether older patient age (65 years and older) was a risk factor for increased rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Noseda, Roberta, Bonaldo, Giulia, Motola, Domenico, Stathis, Anastasios, Ceschi, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961480/
https://www.ncbi.nlm.nih.gov/pubmed/33800813
http://dx.doi.org/10.3390/cancers13051131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961480/
https://www.ncbi.nlm.nih.gov/pubmed/33800813
http://dx.doi.org/10.3390/cancers13051131

Ejemplares similares